03 December 2002 - U.S. Patent and Trademark Office

DEC 3, 2002 U.S. PATENT AND TRADEMARK OFFICE TM 45
SN 76-072,004. BIOVISION AG, D-30625 HANNOVER, FED
REP GERMANY, BY CHANGE OF NAME BIOVISION
GMBZ & CO. KG, D-30625 HANNOVER, FED REP
GERMANY, FILED 6-16-2000.
OWNER OF FED REP GERMANY REG. NO. 39981792,
DATED 2-21-2000, EXPIRES 12-31-2009.
THE STIPPLING IN THE MARK IS A FEATURE OF THE
MARK AND IS NOT INTENDED TO INDICATE COLOR.
THE WORD PORTION OF THE MARK IS IN THE COLOR
BLUE AND DESIGN PORTION IS THE COLOR RED-
BROWN.
CLASS 1—CHEMICALS
FOR CHEMICALS USED IN SCIENCE, NAMELY,
PEPTIDES, PROTEINS, NUCLEIC ACIDS, ANTIBODIES,
ENZYMES, GROWTH FACTORS AND DERIVATIVES
THEREOF, FOR SCIENTIFIC ANALYTICAL USE, NOT
FOR MEDICAL OR VETERINARY PURPOSES; CHEMI-
CALS USED FOR DERIVATIZATION OF PEPTIDES,
PROTEINS OR NUCLEIC ACIDS USED IN SCIENTIFIC
AND MEDICAL RESEARCH; CULTURES OF MICRO-
ORGANISMS FOR MEDICAL RESEARCH USES; CHE-
MICAL PREPARATIONS FOR MEDICAL RESEARCH
USES(U.S.CLS.1,5,6,10,26AND46).
CLASS 5—PHARMACEUTICALS
FOR MEDICAL, VETERINARY AND PHARMACEU-
TICAL PREPARATIONS, NAMELY, MEDICINES FOR
DIAGNOSIS OR TREATMENT OF DEGENERATIVE
DISEASES, VARIOUS TYPES OF CANCER, BONE DIS-
EASES, INFLAMMATORY DISEASES OR DENTAL
TREATMENT; PHARMACEUTICALLY ACTIVE SUB-
STANCES USED IN THE TREATMENT OF DEGENERA-
TIVE DISEASES, VARIOUS TYPES OF CANCER, BONE
DISEASES, INFLAMMATORY DISEASES OR DENTAL
TREATMENT, NAMELY, PEPTIDES, PROTEINS, HOR-
MONES, GROWTH FACTORS, ANTIBODIES OR NU-
CLEIC ACIDS, AND DERIVATIVES THEREOF;
MICROBIOLOGICAL FOR MEDICAL DIAGNOSTIC
AND LABORATORY USES, VETERINARY AND PHAR-
MACEUTICAL PURPOSES, NAMELY, PEPTIDES, PRO-
TEINS, HORMONES, ANTIBODIES OR NUCLEIC
ACIDS, AND DERIVATIVES THEREOF; CULTURES OF
MICROORGANISMS FOR MEDICAL DIAGNOSTIC
AND LABORATORY USES, VETERINARY AND PHAR-
MACEUTICAL PURPOSES (U.S. CLS. 6, 18, 44, 46, 51
AND 52).
CLASS 42—SCIENTIFIC, COMPUTER AND
LEGAL SERVICES
FOR SCIENTIFIC RESEARCH; INDUSTRIAL RE-
SEARCH IN THE PHARMACEUTICAL, BIOTECHNOL-
OGY, HEALTHCARE AND CHEMICAL INDUSTRIES;
MEDICAL TESTING, MEDICAL DIAGNOSIS AND ANA-
LYSES OF CLINICAL SAMPLES; NON-MEDICAL ANA-
LYSES, NAMELY, BIOCHEMICAL ANALYSES,
DISCOVERY OF DRUG TARGETS OR CANDIDATES,
ANALYSES FOR CLINICAL DEVELOPMENT OF MED-
ICINES, PROCESS CONTROL IN BIOTECHNOLOGY,
ANALYSES OF VETERINARY SAMPLES OR TEST
ANIMALS, PHENOTYPING OR ORGANISMS; SERVICES
IN THE FIELD OF DIAGNOSTICS, NAMELY, DETEC-
TION AND MEASUREMENT OF MARKERS OR MAR-
KER PANELS, MEASUREMENT OF SUBSTANCES IN
BODY FLUIDS, MAKER IDENTIFICATION, MARKER
VALIDATION, ASSAY DEVELOPMENT, SERVICES IN
THE FIELD OF THE DEVELOPMENT OF PHARMACEU-
TICALLY ACTIVE SUBSTANCES, NAMELY, ANALYSES
OF CLINICAL DRUG DEVELOPMENT, EG FOR PA-
TIENT STRATIFICATION, BIOMARKERS AND DRUG
EFFECT MONITORING, PHENOTYPING OF TEST ANI-
MALS, IDENTIFICATION OF DRUG TARGETS OR
CANDIDATES; ACQUISITION, LICENSING AND UTILI-
ZATION OF INDUSTRIAL PROPERTY RIGHTS FOR
OTHERS (U.S. CLS. 100 AND 101).
SN 76-076,485. GLOBAL HEALTH CARE EXCHANGE, LLC,
COOK COUNTY, IL. FILED 6-23-2000.
GLOBAL HEALTH CARE
EXCHANGE
NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO
USE "EXCHANGE", APART FROM THE MARK AS
SHOWN.
SEC. 2(F).
CLASS 35—ADVERTISING AND BUSINESS
FOR PROVIDING OPERATIONAL SUPPORT AND
MATERIALS MANAGEMENT SYSTEMS IN THE FILES
OF HEALTH CARE HOSPITAL MANAGEMENT,
NAMELY, PROVIDING ON-LINE PROCUREMENT,
COMPARATIVE PRICING ANALYSIS, INVENTORY
CONTROL, AND MATCHING OF, PROVIDERS AND
CONSUMERS OF HEALTH-RELATED GOODS AND
SERVICES; OPERATION OF AN ON-LINE WEB SITE
AND ELECTRONIC EXCHANGE FOR BUSINESS-TO-
BUSINESS TRANSACTIONS IN THE FIELD MEDICAL
PRODUCTS AND SERVICES; PROVIDING INFORMA-
TION VIA AN ON-LINE GLOBAL COMPUTER NET-
WORK RELATING TO CLINICAL INFORMATION IN
THE FIELD OF MEDICAL PRODUCTS AND SERVICES
(U.S. CLS. 100, 101 AND 102).
FIRST USE 3-0-2000; IN COMMERCE 3-0-2000.
CLASS 42—SCIENTIFIC, COMPUTER AND
LEGAL SERVICES
FOR PROVIDING INFORMATION VIA AN ON-LINE
GLOBAL COMPUTER NETWORK RELATING TO CLIN-
ICAL INFORMATION IN THE FIELD OF MEDICAL
PRODUCTS AND SERVICES (U.S. CLS. 100 AND 101).
FIRST USE 3-0-2000; IN COMMERCE 3-0-2000.